Knochendestruierende Schwellung der Nasenflanke = Bone damaging swelling of the side of the noseÖZTÜRK, E; OTTERBACH, F; WERNER, M et al.HNO. Hals-, Nasen-, Ohrenärzte. 2006, Vol 54, Num 12, pp 958-961, issn 0017-6192, 4 p.Article

Telomerase activity in human proliferative breast lesionsPOREMBA, C; BÖCKER, W; WILLENBRING, H et al.International journal of oncology. 1998, Vol 12, Num 3, pp 641-648, issn 1019-6439Article

Relationship and prognostic significance of phospho-(serine 166)-murine double minute 2 and akt activation in node-negative breast cancer with regard to p53 expressionSCHMITZ, K. J; GRABELLUS, F; CALLIES, R et al.Virchows Archiv. 2006, Vol 448, Num 1, pp 16-23, issn 0945-6317, 8 p.Article

Purpura fulminans: Fatale folge einer alltäglichen Therapie? = Purpura fulminans. A fatal consequence of a widely used medication?HENGGE, U. R; JOCHUM, C; TSCHAKARJAN, E et al.Hautarzt. 2002, Vol 53, Num 7, pp 483-487, issn 0017-8470Article

Comparative genomic hybridization of ductal carcinoma in situ of the breast: Evidence of multiple genetic pathwaysBUERGER, H; OTTERBACH, F; SIMON, R et al.Journal of pathology. 1999, Vol 187, Num 4, pp 396-402, issn 0022-3417Article

Erdheim-Chester disease: case report with multisystemic manifestations including testes, thyroid, and lymph nodes, and a review of literatureSHEU, S-Y; WENZEL, R. R; KERSTING, C et al.Journal of clinical pathology. 2004, Vol 57, Num 11, pp 1225-1228, issn 0021-9746, 4 p.Article

Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breastOTTERBACH, F; BANKFALVI, A; BERGNER, S et al.Histopathology. 2000, Vol 37, Num 3, pp 232-240, issn 0309-0167Article

Diagnostic accuracy of fused positron emission tomography/ magnetic resonance mammography: initial resultsHEUSNER, T. A; HAHN, S; JONKMANNS, C et al.British journal of radiology. 2011, Vol 84, Num 998, pp 126-135, issn 0007-1285, 10 p.Article

Overexpression of cyclo-oxygenase-2 is an independent predictor of unfavourable outcome in node-negative breast cancer, but is not associated with protein kinase B (Akt) and mitogen-activated protein kinase (ERK1/2, p38) activation or with her-2/neu siqnallinq pathwaysSCHMILZ, K. J; CALLIES, R; WOHLSCHLAEGER, J et al.Journal of clinical pathology. 2006, Vol 59, Num 7, pp 685-691, issn 0021-9746, 7 p.Article

Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypesBUERGER, H; OTTERBACH, F; SIMON, R et al.Journal of pathology. 1999, Vol 189, Num 4, pp 521-526, issn 0022-3417Article

Plasma-induced surface modifications on silicone intraocular lenses : chemical analysis and in vitro characterizationHETTLICH, H.-J; OTTERBACH, F; MITTERMAYER, C et al.Biomaterials. 1991, Vol 12, Num 5, pp 521-524, issn 0142-9612, 4 p.Article